AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,406,000 | -15.5% | 1,670,000 | 0.0% | 0.21% | -9.6% |
| Q4 2021 | $13,494,000 | -39.5% | 1,670,000 | -26.6% | 0.23% | -34.3% |
| Q3 2021 | $22,295,000 | -24.1% | 2,275,000 | -47.9% | 0.35% | -31.5% |
| Q2 2021 | $29,376,000 | -25.6% | 4,365,000 | 0.0% | 0.51% | -25.0% |
| Q1 2021 | $39,460,000 | +35.3% | 4,365,000 | 0.0% | 0.68% | +35.7% |
| Q4 2020 | $29,158,000 | +37.7% | 4,365,000 | +3.9% | 0.50% | +66.8% |
| Q3 2020 | $21,168,000 | -42.6% | 4,200,000 | -8.0% | 0.30% | -58.7% |
| Q2 2020 | $36,890,000 | +6.4% | 4,565,655 | +4.6% | 0.73% | -37.7% |
| Q1 2020 | $34,663,000 | – | 4,365,655 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |